Older adults are more susceptible to severe breakthrough COVID-19, studies show
Health officials say older adults are more at risk for severe COVID-19 breakthrough cases due to underlying medical conditions and less robust immune systems.
September was worst month for child COVID-19 infections, AAP says
The American Academy of Pediatrics also said the overall COVID-19 infection rate is 8,035 cases per 100,000 children in the population.
Treasury official claims inflation part of ‘economy in transition,’ only way out is 100% global vaccination
The comments are the latest in confusing, conflicting messaging on inflation from the Biden administration.
Fauci: Halloween, Thanksgiving, Christmas gatherings safe for vaccinated people
Dr. Anthony Fauci said it is OK for vaccinated people to attend the upcoming Halloween, Thanksgiving and Christmas gatherings, but he has a warning for the unvaccinated population.
Demand for ivermectin for hospitalized COVID patients prompts lawsuits
Judges around the country are increasingly being asked to weigh in on the deworming drug ivermectin as a COVID-19 treatment.
Nursing school applications rise amid COVID-19 burnout among staff
Nurses around the U.S. are getting burned out by the COVID-19 crisis and quitting, yet applications to nursing schools are rising.
How to choose the right health plan for you
Medicare enrollment has begun. FOX 26 Consumer Reporter has some Smart Sense on choosing a plan.
90,000 US COVID-19 deaths since June were preventable, Kaiser Family Foundation says
The analysis estimated how many COVID-19 deaths were among unvaccinated adults and could have been prevented since June 2021 “when safe and effective COVID-19 vaccines became widely available to all adults in the U.S.”
CDC issues 2021 holiday COVID-19 guidance urging vaccination ahead of gatherings
The U.S. Centers for Disease Control and Prevention’s guidance urges people to get vaccinated ahead of the holidays if they haven't done so already.
J&J COVID-19 booster: FDA panel endorses extra dose at least 2 months later
An FDA panel on Friday voted to recommend a booster dose of the single-shot Johnson & Johnson COVID-19 vaccine at least two months later.
Italy's mandatory COVID-19 pass for all workers prompts protests
All workers across public and private sectors in Italy are required to show a COVID-19 health pass to get into their place of employment.
US to lift travel ban for vaccinated foreign nationals on Nov. 8
The White House is expected to announce fully vaccinated international travelers who are foreign nationals will be allowed into the united states starting Nov. 8.
Moderna COVID-19 boosters: FDA panel endorses lower-dose shots for seniors, high risk
The FDA’s independent advisory panel endorsed lower-dose Moderna booster shots for seniors and other high-risk groups.
Texas lawmakers wage emotional debate over transgender athletic participation
FOX 26 Political Reporter Greg Groogan explains the debate going on in Austin.
Biden: Number of unvaccinated in US ‘unacceptably high’ amid measured progress
President Joe Biden gave an update on America’s COVID-19 vaccination progress as the rate of administering the shots picked up in recent days.
Dementia signs are in the blood, researchers say
A new study suggests that certain molecules in the blood could indicate impending dementia.
Local woman rings the end of cancer bell at a Houston Texans game
Many cancer patients get to ring a bell at the end of their cancer treatment, often surrounded by family and friends. Elizabeth Weiss got to celebrate her moment in front of tens of thousands of people, after completing four rounds of chemotherapy for breast cancer.
Exercise lowers the risk of breast cancer, studies show
Research suggests exercise could lower the risk of developing breast cancer.
Texas Hospital Association wants hospitals left out of vaccine order
The Texas Hospital Association wants hospitals left out of Gov. Abbott‘s recent order preventing any entity from having a COVID-19 vaccine mandate.
J&J COVID-19 booster shot needs more evidence, FDA analysis suggests
In an online review, FDA scientists didn’t reach a firm conclusion, citing shortcomings with J&J’s data, including little information on protection against the extra-contagious delta variant of the coronavirus.